Chondrosarcoma
What's New
Last Posted: Mar 29, 2023
- Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma.
Dermawan Josephine Kam Tai, et al. Cancer research communications 2023 0 (3) 431-443 - Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.
Mohammad Nissreen, et al. Histopathology 2019 0 (5) 722-730 - Functional testing of thousands of osteoarthritis-associated variants for regulatory activity.
Klein Jason C, et al. Nature communications 2019 0 (1) 2434 - Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph Nancy M, et al. The American journal of surgical pathology 2020 0 (6) 812-819 - Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma.
Murnyak Balazs, et al. Cells 2021 0 (8) - Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma.
Li Binghao, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 0 (23) 6543-6558 - Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes.
Pathmanapan Sinthu, et al. Cancer & metabolism 2021 0 (1) 13 - A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Cross William, et al. Genome medicine 2022 0 (1) 99 - Periosteal chondrosarcoma: A case series in a referral center with survivorship analysis.
Pacheco Marina, et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 0 (8) 1730-1738 - Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis.
Saikiran Reddy M, et al. Cellular signalling 2022 0 110279
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: